<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=319805651697215&amp;ev=PageView&amp;noscript=1">

Cryoport Participates in the Cold Chain BioLogistics Summit on June 16-18th 2014 in San Diego

June 12, 2014

LAKE FOREST, CA – June 12, 2014 — Cryoport, Inc. (OTC BB: CYRX) ("the Company"), the leading provider of advanced cryogenic logistics solutions, today announced that it will be showcasing its patented Cryoport Express® Shippers and its Cryoportal™ Logistics Management Platform, a revolutionary, purpose-built technology which manages and monitors the entire cold chain logistics process for biologic materials, at the BioLogistics Summit in San Diego, California, on June 16th-18th.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, BioLogistics

Cenetron Diagnostics Expands Use of Cryoport’s Cryogenic Logistics Solutions to Support Growth of Molecular Laboratory Services

May 29, 2014

LAKE FOREST, CA – May 29, 2014 — Cryoport, Inc. (OTCBB: CYRX) (“the Company”), the leading provider of advanced cryogenic logistics solutions, today announced that Cenetron Diagnostics has expanded the use of its customized cryogenic logistics solution powered by Cryoport’s CryoportalTM and Cryoport Express® Shippers.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Cenetron

CRYOPORT TO PRESENT AT ANNUAL MARCUM MICROCAP CONFERENCE

May 22, 2014

LAKE FOREST, CA –  May 22, 2014 – Cryoport, Inc. (OTCBB: CYRX) (“the Company”) announced today that it will be a featured presenter at the 3rd Annual Marcum MicroCap Conference on Thursday, May 29, 2014 held at the Grand Hyatt Hotel in New York City.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Marcum

Cryoport Supports International Clinical Trials for Glaukos Corporation with its Comprehensive Turn-Key Frozen Logistics Solution

May 21, 2014

LAKE FOREST, CA – May 21, 2014 — Cryoport, Inc. (OTCBB: CYRX) (“the Company”) today announced that it is providing its turn-key frozen logistics solution to Glaukos Corporation, an ophthalmic medical device company, in support of the iStent clinical trials, shipping biologic material from Armenia to California.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Claukos

Cryoport Reports Fourth Consecutive Quarter of Triple Digit Year-over-Year Revenue Growth for Fourth Quarter of 2014

May 19, 2014

LAKE FOREST, CA – May 19, 2014 — Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the three and twelve month periods ended March 31, 2014.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Revenue

Cryoport Sponsors the 9th Annual World Stem Cells and Regenerative Medicine Congress 2014 in London

April 28, 2014

LAKE FOREST, CA – April 28, 2014 — Cryoport, Inc. (OTCBB: CYRX) (“the Company”) today announced that it is exhibiting its cryogenic logistics solutions, equipped with its cloud-based logistics management platform, the CryoportalTM, and its Cryoport Express® Packaging Solutions at the 9th Annual World Stem Cells and Regenerative Medicine Congress 2014 in London on May 20-22, 2014, at Booth #29.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Stem Cells, World Stem Cell Conference

Cryoport and European Mouse Mutant Archive Enter into Global Agreement to Provide Full-Service Logistics Solutions for Frozen Biomaterials

April 4, 2014

LAKE FOREST, CA – April 1, 2014 — Cryoport, Inc. (OTCBB: CYRX), the only end-to-end cryogenic logistics solutions provider, today announced that it has entered into an agreement with the European Mouse Mutant Archive (“EMMA”), a part of INFRAFRONTIER, the European Research Infrastructure for phenotyping and archiving of model mammalian genomes. Under the agreement, the partners of the EMMA and their global clients will be able to ship frozen biomaterials using Cryoport’s purpose-built cryogenic logistics solutions.  

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Mouse Mutant Archive

Cryoport, Inc. Retains KCSA Strategic Communications as U.S. Investor Relations Counsel

March 27, 2014

LAKE FOREST, California, March 27, 2014 – Cryoport, Inc. (OTC BB: CYRX), the only end-to-end cryogenic logistics solutions provider, today announced that it has retained KCSA Strategic Communications, a leading New York-based communications firm, to lead the Company's investor relations program.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, KCSA Strategic Communications, Investor Relations

Cryoport Increases Revenues By 149% For The First Nine Months of Fiscal 2014

February 13, 2014

LAKE FOREST, CA – February 13, 2014 — Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the quarter and nine months ended December 31, 2013.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Revenue

Liventa Bioscience and Cryoport form Alliance to deliver cell-based biologics to Point-of-Service Orthopedic Care

February 5, 2014

Philadelphia/Lake Forest - February 5, 2014 - Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX)  today  announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa’s cell-based, advanced biologics tissue forms. The exclusive agreement combines Cryoport’s proprietary, purpose-built cold chain logistics solutions for cell-based and advanced biologic tissue forms with Liventa Bioscience’s distribution capability to “point-of-use” US-based orthopedic care providers.

Read More


Tags: Dry Shipper, Frozen Shipping, Clinical Trials Logistics, Cold Chain Logistics, cold shipping, Liventa